The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.